These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37439673)

  • 1. Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases.
    Rosales-Hurtado M; Sannio F; Lari L; Verdirosa F; Feller G; Carretero E; Vo-Hoang Y; Licznar-Fajardo P; Docquier JD; Gavara L
    ACS Infect Dis; 2023 Aug; 9(8):1546-1557. PubMed ID: 37439673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2015 Nov; 70(11):3032-41. PubMed ID: 26311835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K; Macielag MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases.
    Durand-Réville TF; Comita-Prevoir J; Zhang J; Wu X; May-Dracka TL; Romero JAC; Wu F; Chen A; Shapiro AB; Carter NM; McLeod SM; Giacobbe RA; Verheijen JC; Lahiri SD; Sacco MD; Chen Y; O'Donnell JP; Miller AA; Mueller JP; Tommasi RA
    J Med Chem; 2020 Nov; 63(21):12511-12525. PubMed ID: 32658473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of gram-negative β-lactamase producing pathogens in the clinical lab.
    Thomson KS
    Curr Pharm Des; 2013; 19(2):250-6. PubMed ID: 22894616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
    Semenitz E
    Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in regulatory mechanism for inducing β-lactamase in Gram-negative bacteria].
    Xu C; Zhang T; Cai J; Yu Z; Qiu J; Yin J
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1288-1296. PubMed ID: 30152214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
    Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
    J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens.
    Karaiskos I; Galani I; Souli M; Giamarellou H
    Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):133-149. PubMed ID: 30626244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug.
    Evans LE; Krishna A; Ma Y; Webb TE; Marshall DC; Tooke CL; Spencer J; Clarke TB; Armstrong A; Edwards AM
    J Med Chem; 2019 May; 62(9):4411-4425. PubMed ID: 31009558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant
    Lomovskaya O; Rubio-Aparicio D; Tsivkovski R; Loutit J; Dudley M
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0216821. PubMed ID: 34902261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC; Ostergaard BE
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of β-Lactamase-Producing Pathogens.
    Bush K; Bradford PA
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.
    Acar JF; Minozzi C
    Rev Infect Dis; 1986; 8 Suppl 5():S482-6. PubMed ID: 3541133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic Boronates Inhibit All Classes of β-Lactamases.
    Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial susceptibility and molecular mechanisms of resistance to beta-lactams of gram-negative microorganisms--causative agents of nosocomial infections].
    Krapivina IV; Galeeva EV; Veshutova NS; Ivanov DV; Sidorenko SV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):16-20. PubMed ID: 18038541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.